Zobrazeno 1 - 10 of 42 pro vyhledávání: '"D L Bhatt"'
2
Akademický článek
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Autor: J.-P. Collet, H. Thiele, E. Barbato, O. Barthélémy, J. Bauersachs, D. L. Bhatt, P. Dendale, M. Dorobantu, T. Edvardsen, T. Folliguet, Ch. P. Gale, M. Gilard, A. Jobs, P. Jüni, E. Lambrinou, B. S. Lewis, Ju. Mehilli, E. Meliga, B. Merkely, O. Mueller, M. Roffi, F. H. Rutten, D. Sibbing, G. C.M. Siontis
Publikováno v: Российский кардиологический журнал, Vol 26, Iss 3 (2021)
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Externí odkaz: https://doaj.org/article/873ad287bb7d4778ae7d3f443a713a87
Zobrazit plný text záznamu
3
Eicosapentaenoic acid (EPA) treatment increased the ratio to arachidonic (EPA/AA) and reduced adhesion molecule expression in vascular endothelium during inflammation
Autor: S C R Sherratt, P Libby, D L Bhatt, P Mason
Publikováno v: European Journal of Preventive Cardiology. 30
Funding Acknowledgements Type of funding sources: Private company. Main funding source(s): Amarin Pharmaceutical, Inc. Elucida Research LLC. Background Omega-3 fatty acid (n3-FA) treatment reduces cardiovascular (CV) risk in relation to circulating E
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9088f7e1189b65b64f1ba52b7fc1235f
https://doi.org/10.1093/eurjpc/zwad125.177
Zobrazit plný text záznamu
4
Eicosapentaenoic acid (EPA) reduced expression of neutrophil activation proteins in endothelial cells during challenge with angiotensin II (Ang II) and cytokines
Autor: S C R Sherratt, P Libby, D L Bhatt, P Mason
Publikováno v: European Journal of Preventive Cardiology. 30
Funding Acknowledgements Type of funding sources: Private company. Main funding source(s): Amarin Pharmaceutical, Inc. Elucida Research LLC. Background Neutrophil degranulation contributes to atherogenesis and tissue injury in response to cytokine re
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5ef719655f0373528523c7d52a24fde7
https://doi.org/10.1093/eurjpc/zwad125.159
Zobrazit plný text záznamu
5
A safety and pharmacodynamic study of the highly selective aldosterone synthase inhibitor PB6440 in the cynomolgus monkey
Autor: B Pitt, D L Bhatt, R J Schotzinger, E Pacyniak, J Jowett, J S Lee
Publikováno v: European Heart Journal. 43
Background Aldosterone is an important mediator of hypertension, particularly resistant hypertension, heart failure, and chronic kidney disease. PB6440 is a potent inhibitor of aldosterone synthase (CYP11B2) with high selectivity over the closely rel
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9939cc3d6466cd3c93634b3453b83790
https://doi.org/10.1093/eurheartj/ehac544.3061
Zobrazit plný text záznamu
6
Longer-term safety of alirocumab with 24,610 patient-years of placebo-controlled observation: further insights from the ODYSSEY OUTCOMES trial
Autor: S Goodman, P G Steg, M Szarek, D L Bhatt, V A Bittner, R Diaz, R A Harrington, J W Jukema, H D White, A M Zeiher, G Manvelian, Y Poulouin, M Scemama, W Stipek, G G Schwartz
Publikováno v: European Heart Journal. 43
Background In the ODYSSEY OUTCOMES trial (NCT01663402), alirocumab, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 (PCSK9), lowered low-density lipoprotein cholesterol from ∼2.3 mmol/L to ∼1.0 mmol/L at 4 months, reduced t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::64be7a42f5a99300795b5de4f4ad2cfd
https://doi.org/10.1093/eurheartj/ehac544.1233
Zobrazit plný text záznamu
7
Serial high-sensitivity troponin T concentrations and long-term outcomes in patients with suspected acute coronary syndrome
Autor: M Pareek, K H Kragholm, M Vaduganathan, J L Pallisgaard, C Byrne, A M D Kristensen, T Biering-Sorensen, C J Lee, A N Bonde, M Maeng, E L Fosbol, L Kober, G H Gislason, D L Bhatt, C Torp-Pedersen
Publikováno v: European Heart Journal. 43
Background High-sensitivity troponin assays allow for accurate and rapid rule-in or rule-out of myocardial infarction (MI) among patients with acute-onset chest pain. However, prognostic implications of serial high-sensitivity troponin concentrations
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a193a7196df521d7bbea15aab894e499
https://doi.org/10.1093/eurheartj/ehac544.1348
Zobrazit plný text záznamu
8
Lipoprotein(a) and the effect of alirocumab on coronary and non-coronary revascularization following acute coronary syndrome
Autor: P Steg, M Szarek, M Valgimigli, S Islam, A M Zeiher, D L Bhatt, V A Bittner, R Diaz, S G Goodman, R A Harrington, J W Jukema, R Pordy, M Scemama, H D White, G G Schwartz
Publikováno v: European Heart Journal. 43
Background Many patients require arterial revascularization after an index ACS. Lipoprotein(a) is thought to play a pathogenic role in atherothrombosis. In the ODYSSEY OUTCOMES trial, the PCSK9 inhibitor alirocumab reduced major adverse cardiovascula
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0456672f162cdcab57c1da7d3fcee816
https://doi.org/10.1093/eurheartj/ehac544.1386
Zobrazit plný text záznamu
9
Blood pressure and clinical outcomes in patients with diabetes and stable coronary artery disease in THEMIS
Autor: M Pareek, D L Bhatt, L Zheng, J J Lee, L A Leiter, T Simon, S R Mehta, R A Harrington, K Fox, A Himmelmann, E Vidal-Petiot, P G Steg
Publikováno v: European Heart Journal. 43
Background Various BP characteristics, e.g., systolic blood pressure (SBP), diastolic blood pressure (DBP), and pulse pressure (PP), as well as heart rate (HR) may affect the risk of both cardiovascular events and bleeding events. However, the exact
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2a422467966e3e3a3a67e4160d1a6e5a
https://doi.org/10.1093/eurheartj/ehac544.1226
Zobrazit plný text záznamu
10
Marital status, cardiovascular events, and intensive blood pressure lowering among men and women in the Systolic Blood Pressure Intervention Trial
Autor: M Pareek, C Byrne, A D Mikkelsen, A M Dyrvig Kristensen, M Vaduganathan, T Biering-Sorensen, K H Kragholm, M B Mortensen, A Singh, M H Olsen, D L Bhatt
Publikováno v: Pareek, M, Byrne, C, Mikkelsen, A D, Kristensen, A M D, Vaduganathan, M, Biering-Sorensen, T, Kragholm, K H, Mortensen, M B, Singh, A, Olsen, M H & Bhatt, D L 2021, ' Marital status, cardiovascular events, and intensive blood pressure lowering among men and women in the Systolic Blood Pressure Intervention Trial ', European Heart Journal, vol. 42, no. Suppl. 1, pp. 2312 . https://doi.org/10.1093/eurheartj/ehab724.2312
Background Married persons may have lower rates of mortality and cardiovascular disease (CV) than unmarried persons although data regarding potential differences between men and women are conflicting. The Systolic Blood Pressure Intervention Trial (S
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6db227fc2e4f53e2018d9ee1d28b9d5d
https://vbn.aau.dk/da/publications/742878af-2116-48d8-833a-77114e7bd9e9
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje